168 related articles for article (PubMed ID: 17317680)
1. Delayed expression of apoptotic and cell-cycle control genes in carcinogen-exposed bladders of mice lacking p53.S389 phosphorylation.
Bruins W; Jonker MJ; Bruning O; Pennings JL; Schaap MM; Hoogervorst EM; van Steeg H; Breit TM; de Vries A
Carcinogenesis; 2007 Aug; 28(8):1814-23. PubMed ID: 17317680
[TBL] [Abstract][Full Text] [Related]
2. Lack of p53 Ser389 phosphorylation predisposes mice to develop 2-acetylaminofluorene-induced bladder tumors but not ionizing radiation-induced lymphomas.
Hoogervorst EM; Bruins W; Zwart E; van Oostrom CT; van den Aardweg GJ; Beems RB; van den Berg J; Jacks T; van Steeg H; de Vries A
Cancer Res; 2005 May; 65(9):3610-6. PubMed ID: 15867355
[TBL] [Abstract][Full Text] [Related]
3. p53 heterozygosity results in an increased 2-acetylaminofluorene-induced urinary bladder but not liver tumor response in DNA repair-deficient Xpa mice.
Hoogervorst EM; van Oostrom CT; Beems RB; van Benthem J; Gielis S; Vermeulen JP; Wester PW; Vos JG; de Vries A; van Steeg H
Cancer Res; 2004 Aug; 64(15):5118-26. PubMed ID: 15289314
[TBL] [Abstract][Full Text] [Related]
4. A survivin gene signature predicts aggressive tumor behavior.
Salz W; Eisenberg D; Plescia J; Garlick DS; Weiss RM; Wu XR; Sun TT; Altieri DC
Cancer Res; 2005 May; 65(9):3531-4. PubMed ID: 15867343
[TBL] [Abstract][Full Text] [Related]
5. Gene expression and apoptosis induction in p53-heterozygous irradiated mice.
di Masi A; Antoccia A; Dimauro I; Argentino-Storino A; Mosiello A; Mango R; Novelli G; Tanzarella C
Mutat Res; 2006 Feb; 594(1-2):49-62. PubMed ID: 16169021
[TBL] [Abstract][Full Text] [Related]
6. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.
Smith ND; Rubenstein JN; Eggener SE; Kozlowski JM
J Urol; 2003 Apr; 169(4):1219-28. PubMed ID: 12629332
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling of p53(+/-) knockout and wild-type mice following diethylstilbestrol administration.
Salleh MN; Ismail P; Abdullah AS; Taufiq-Yap YH
IUBMB Life; 2004 Jul; 56(7):409-16. PubMed ID: 15545218
[TBL] [Abstract][Full Text] [Related]
8. Tissue-specific p53 responses to ionizing radiation and their genetic modification: the key to tissue-specific tumour susceptibility?
Coates PJ; Lorimore SA; Lindsay KJ; Wright EG
J Pathol; 2003 Nov; 201(3):377-88. PubMed ID: 14595749
[TBL] [Abstract][Full Text] [Related]
9. Nrf2 and p53 cooperatively protect against BBN-induced urinary bladder carcinogenesis.
Iida K; Itoh K; Maher JM; Kumagai Y; Oyasu R; Mori Y; Shimazui T; Akaza H; Yamamoto M
Carcinogenesis; 2007 Nov; 28(11):2398-403. PubMed ID: 17602169
[TBL] [Abstract][Full Text] [Related]
10. The absence of Ser389 phosphorylation in p53 affects the basal gene expression level of many p53-dependent genes and alters the biphasic response to UV exposure in mouse embryonic fibroblasts.
Bruins W; Bruning O; Jonker MJ; Zwart E; van der Hoeven TV; Pennings JL; Rauwerda H; de Vries A; Breit TM
Mol Cell Biol; 2008 Mar; 28(6):1974-87. PubMed ID: 18195040
[TBL] [Abstract][Full Text] [Related]
11. Dissecting functional roles of p53 N-terminal transactivation domains by microarray expression analysis.
Ohki R; Kawase T; Ohta T; Ichikawa H; Taya Y
Cancer Sci; 2007 Feb; 98(2):189-200. PubMed ID: 17233836
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of genes associated with cell proliferation and apoptosis induced by okadaic acid during the transformation process of BALB/c 3T3 cells.
Ao L; Liu JY; Gao LH; Liu SX; Yang MS; Huang MH; Cao J
Toxicol In Vitro; 2008 Feb; 22(1):116-27. PubMed ID: 17935941
[TBL] [Abstract][Full Text] [Related]
13. Elevated expression of ribosomal protein genes L37, RPP-1, and S2 in the presence of mutant p53.
Loging WT; Reisman D
Cancer Epidemiol Biomarkers Prev; 1999 Nov; 8(11):1011-6. PubMed ID: 10566557
[TBL] [Abstract][Full Text] [Related]
14. Human bladder cancer cells undergo cisplatin-induced apoptosis that is associated with p53-dependent and p53-independent responses.
Konstantakou EG; Voutsinas GE; Karkoulis PK; Aravantinos G; Margaritis LH; Stravopodis DJ
Int J Oncol; 2009 Aug; 35(2):401-16. PubMed ID: 19578756
[TBL] [Abstract][Full Text] [Related]
15. Multiple response elements and differential p53 binding control Perp expression during apoptosis.
Reczek EE; Flores ER; Tsay AS; Attardi LD; Jacks T
Mol Cancer Res; 2003 Dec; 1(14):1048-57. PubMed ID: 14707288
[TBL] [Abstract][Full Text] [Related]
16. The tumor-promoting activity of 2-acetylaminofluorene is associated with disruption of the p53 signaling pathway and the balance between apoptosis and cell proliferation.
Pogribny IP; Muskhelishvili L; Tryndyak VP; Beland FA
Toxicol Appl Pharmacol; 2009 Mar; 235(3):305-11. PubMed ID: 19167416
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of hydroxyurea(HU)-induced apoptosis in the mouse fetal brain.
Woo GH; Bak EJ; Nakayama H; Doi K
Neurotoxicol Teratol; 2006; 28(1):125-34. PubMed ID: 16356682
[TBL] [Abstract][Full Text] [Related]
18. Arsenite inhibits p53 phosphorylation, DNA binding activity, and p53 target gene p21 expression in mouse epidermal JB6 cells.
Tang F; Liu G; He Z; Ma WY; Bode AM; Dong Z
Mol Carcinog; 2006 Nov; 45(11):861-70. PubMed ID: 16739126
[TBL] [Abstract][Full Text] [Related]
19. Variation in the expression of p53, c-myc, and bcl-2 oncoproteins in individual patient cultures of normal urothelium exposed to cobalt 60 gamma-rays and N-nitrosodiethanolamine.
Harney JV; Seymour CB; Murphy DM; Mothersill C
Cancer Epidemiol Biomarkers Prev; 1995 Sep; 4(6):617-25. PubMed ID: 8547828
[TBL] [Abstract][Full Text] [Related]
20. Hypersensitivity to chromium-induced DNA damage correlates with constitutive deregulation of upstream p53 kinases in p21-/- HCT116 colon cancer cells.
Hill R; Leidal AM; Madureira PA; Gillis LD; Cochrane HK; Waisman DM; Chiu A; Lee PW
DNA Repair (Amst); 2008 Feb; 7(2):239-52. PubMed ID: 18024214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
